Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Vitamin E Polyethylene Glycol Succinate, known in the pharma field for its code Tocophersolan, steps up as a water-soluble derivative of natural vitamin E. The most common shorthand on shipping papers is TPGS, and it’s present across the bulk ingredient market for manufacturers working to improve bioavailability of poorly water-soluble drugs. Its backbone carries the familiar antioxidant strength of alpha-tocopherol, bound covalently to succinic acid and further connected to polyethylene glycol. The material pulls double duty: on one hand, it stabilizes drug formulations; on the other, it acts as a functional excipient for improved oral and topical delivery. HS Code 2907.19 marks its regulatory path for customs. Those working in pharmaceuticals and nutraceuticals, especially in solubilization or emulsification projects, tend to handle the product in various forms including flakes, solids, amorphous powders, pearls, viscous liquids, even crystalized solutions depending on supplier specs.
A closer look at the molecular structure shows TPGS carries polyoxyethylene backbones grafted onto vitamin E’s chromanol ring at the succinate moiety. The molecular formula comes out as C33H54O8 (for the core), though the chain length of PEG changes batch-to-batch, stretching its formula in practical application. Typical average molecular weight hovers near 1513 g/mol. As for density: at 20°C, expect between 1.06 and 1.12 grams per cubic centimeter, pointing to its semi-solid, pasty or waxy character in ambient warehouse conditions. Material scans in white or pale-yellow, sometimes nearly transparent, depending on supply source or grade. Solutions made with TPGS show cloud points above 40 °C, much higher than many excipients, which turns useful for formulating stable emulsions under a range of storage conditions.
Pick up a sample of TPGS and you get a waxy chunk or fine powder; larger bulk orders might come as beads or pearls in lined drums. The compound’s solubility in water stands out, since natural vitamin E shows weak dispersal in water. PEGylation shifts hydrophilicity upward, allowing clear preparation even in low-ionic strength environments, which means less need for cosolvents. In solid form, the melting range typically falls between 37-41°C (body temperature is within the same range), which matters for oral formulations aiming at pre-gastric absorption or early gut dispersal. Packagers and logistics teams will see TPGS flagged as not hazardous under normal shipping, though like any raw material, dust control, respiratory protection, and eye barriers are standard in cGMP facilities.
Solid and stable at room temperature, TPGS brings a lower risk profile than many surfactants. Acute inhalation or skin exposure studies in lab animals show a high margin of safety, making it a preferred excipient in pediatric and geriatric medicines. Oral LD50 in rodents sits above 7,000 mg/kg, suggesting limited toxicity within anticipated exposure levels for tablet or capsule manufacture. At the same time, any raw material with PEG in the backbone could cause mild GI upset in sensitive patients. While TPGS is not classified as harmful or hazardous as per GHS labeling, product stewardship still calls for careful ingredient tracking and supplier qualification, especially as regional supply chain differences can alter trace residual levels of unreacted ethylene oxide. Waste streams containing TPGS should go through approved disposable routes to prevent chemical buildup in wastewater due to its high stability and low biodegradability.
In my years coordinating with R&D and regulatory teams in pharma supply, genuine value from TPGS comes in the blend of solubilizer, antioxidant, and absorption-enhancing capabilities. Regulatory approval across BP, EP, and USP monographs means global manufacturers can site the same raw material in multi-region filings, smoothing the path from phase one trials to final marketed product. The reason this matters: many modern APIs stay stuck in poor aqueous solubility traps, and a safe, highly-characterized excipient like TPGS unlocks new approaches for oral, topical, and lipid-based parenteral solutions. I have seen its performance first-hand in softgel lines where heat and shear often break less robust excipients, but TPGS provides both miscibility and chemical stability. It works well for vitamin formulations, too, especially for patients unable to absorb natural vitamin E because of fat malabsorption.
Keeping pace with product quality starts at procurement. Variability in chain length, color, and residual solvents can affect appearance and taste in finished goods. Methodical qualification, including melt point calibration and PEG chain length verification, sorts out these concerns early. Labs use FTIR, HPLC, and titration for purity tests, catching out-of-spec barrels before they hit blends. For manufacturers, storage under low humidity and well-sealed packaging prevents clumping and protects oxidative stability. As demand rises for clean-label formulations and supply chain transparency, some producers have shifted to non-animal, synthetic vitamin E origins, giving extra peace of mind for kosher, halal, or vegan demands.
TPGS, due to its detailed structure, straightforward supply, broad regulatory coverage, and real-world performance, has become one of the more reliable specialty excipients outfitting today’s pharma and nutraceutical manufacturing lines. With advances in customized molecule design and green chemistry, the next generation of TPGS-like materials could deliver new approaches for drug delivery, tackling the hardest solubility challenges without losing sight of patient safety, regulatory compliance, or environmental stewardship.
Chengguan District, Lanzhou, Gansu, China
